CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
First case description of a quadruple therapy with silibinin, telaprevir, ribavirin and pegIFNα2a in a liver transplanted patient with chronic Hepatitis C Virus infection
DOI 10.1055/s-0033-1352801
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Roos, V Lohmann, W Stremmel, C Eisenbach
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: After liver transplantation antiviral therapy of chronic Hepatitis C Virus (HCV) reinfection of the graft remains challenging. Protease inhibitor based antiviral therapy seems to improve outcome of antiviral therapy but is still limited by dependency on previous treatment outcome with standard of care (SOC). Silibinin (SIL) has already proven potent antiviral efficacy in the pre-, peri- and post-transplantatio…
Zitieren
Zitierempfehlung
K Roos, V Lohmann, W Stremmel, C Eisenbach (2013) First case description of a quadruple therapy with silibinin, telaprevir, ribavirin and pegIFNα2a in a liver transplanted patient with chronic Hepatitis C Virus infection. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352801
Mit CareLit weiterarbeiten